110 | HIGH PFS WITH LOW INFIELD RECURRENCES AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE NODAL FOLLICULAR LYMPHOMA: FINAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3)
Klaus Herfarth(Heidelberg University), M. Dreyling(LMU Klinikum), Roswitha Forstpointner(LMU Klinikum), Chiara de Colle(Ospedale Sacro Cuore Don Calabria), Christian Baues(University Hospital Cologne), Julia von Tresckow(Essen University Hospital), Stefan Wirths(University of Tübingen), Stephanie E. Combs(TUM Klinikum), Georg Lenz(University Hospital Münster), Laila König(Heidelberg University), Thomas Gauler, Julia Meißner(Heidelberg University), C. Buske(University Hospital Ulm), Simon Heidegger, M. Li(LMU Klinikum), Christian Schölz(Department of Virology), Ulrike Hoeller(Vivantes Klinikum), Kai Hübel(University Hospital Cologne), Eleni Mavriopoulou(Heidelberg University), Hans‐Theodor Eich(Johannes Gutenberg University Mainz), Peter Thalmann(Heidelberg University), Christiane Pott(University Hospital Schleswig-Holstein), Thomas Wiegel(University Hospital Ulm)
Cited by 0
Related Papers
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
|Proceedings of the National Academy of Sciences|2008|985